A deeper understanding of the gene regulatory networks of erythropoiesis and their interference with BG-specific gene regulation could help to shed new light on the many clinical manifestations, where ABO BG-dependent differences for the development and progression of disease, such as myocardial infarction, thrombosis and infection, are observed. Here, ABO is linked to deep vein thrombosis.